CC chemokines induce the generation of killer cells from CD56+ cells
Abstract
We describe here that members of the CC chemokines exhibit biological activities other than chemotaxis. Macrophage inflammatory protein (MIP)‐1α, MIP‐1β, monocyte chemoattractant protein‐1 and RANTES, but not interleukin (IL)‐8, induce the generation of cytolytic cells, designated here as CHAK (CC chemokine‐activated killer) cells to distinguish them from IL‐2‐activated (LAK) cells. Like IL‐2, CC chemokines can induce the proliferation and activation of killer cells. While incubating CC chemokines with CD4+ or CD8+ cells did not generate CHAK activity, all CC chemokines were capable of inducing CHAK activity upon incubating with CD56+ cells, suggesting that the primary effectors are NK cells. However, the presence of other cell types, such as CD4+ or CD8+, are necessary to induce the proliferation of CD56+ cells. Confirming the involvement of T cell‐derived factors in inducing the proliferation of these cells, anti‐IL‐2 and anti‐interferon‐γ, but not anti‐IL‐1β, anti‐tumor necrosis factor‐α, anti‐IL‐8, or anti‐granulocyte/monocyte‐colony‐stimulating factor inhibited RANTES‐induced proliferation of nylon wool column‐nonadherent cells. Our results may have important clinical applications for the utilization of CHAK cells in the treatment of cancer and immunodeficient patients.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CCL5 can mediate the activation of NK cells into chemokine-activated killers (CHAK).
“Aside from this role, it can also mediate the activation of NK cells into chemokine-activated killers (CHAK) (76).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [76]
Cited by
Sorted by citations
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
Arango Duque, G., & Descoteaux, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00491 · Cited by 2,708 · see citing works
“Aside from this role, it can also mediate the activation of NK cells into chemokine-activated killers (CHAK) (76).”
BackgroundMgrditchian, T., Arakelian, T., Paggetti, J., Noman, M. Z., Viry, E., Moussay, E., Van Moer, K., Kreis, S., Guerin, C., Buart, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703921114 · Cited by 226 · see citing works
Biocompatibility of implants: lymphocyte/macrophage interactions
Anderson, J. M., & McNally, A. K. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0244-1 · Cited by 226 · see citing works
Chang, D. T., Jones, J. A., Meyerson, H., Colton, E., Kwon, I. K., Matsuda, T., & Anderson, J. M. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31630 · Cited by 114 · see citing works
- Authors
- Maghazachi, A. A., Al‐Aoukaty, A., & Schall, T. J.
- Affiliations
- University of Oslo (NO)
- Corresponding author
- Maghazachi, Azzam A.
- ORCID
- Maghazachi, Azzam A.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1996-02
- Volume
- 26
- Issue
- 2
- Pages
- 315-319
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2052801683
- Cited by
- 163
- References
- 0
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 9 · 2022: 6 · 2021: 10 · 2020: 8 · 2019: 5 · 2018: 11 · 2017: 8 · 2016: 4 · 2015: 8 · 2014: 8 · 2013: 7 · 2012: 8
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- CC chemokines, natural killer cells, CD56+ cells, cytotoxic T lymphocytes, MIP-1α, MIP-1β, MCP-1, RANTES, interleukin-8, T cell-derived factors, interferon-gamma, interleukin-2, cancer immunotherapy, immunodeficient patients
- MeSH terms
- Cell Differentiation, Cell Line, Cytotoxicity, Immunologic, Leukemia, Erythroblastic, Acute, Humans, Lymphocyte Activation, Tumor Cells, Cultured, Monokines, Killer Cells, Lymphokine-Activated, Chemokines, Chemokine CCL2, Chemokine CCL5, CD56 Antigen, Macrophage Inflammatory Proteins, Chemokine CCL4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review